23andMe is upending how we find new drugs, and the CEO says 13 are now in early trialsErin BrodwinFeb 14, 2019, 21:41 IST This is a Business Insider Prime story. Click the link below to read it.Read Full story Add Comment()Comments ()Characters Remaining: 3000SIGN IN WITHFacebookGoogleEmailOR PROCEED WITHOUT REGISTRATIONXSort By:NewestOldestDiscussedUp VotedDown VotedBe the first one to comment.We have sent you a verification email. This comment will be published once verification is done.Next StoryTHE DIGITAL HEALTH ECOSYSTEM: An in-depth examination of the players and tech trends reshaping the future of healthcareRelated StoriesHelp us improve Markets Insider, and get a free month of BI PrimeInsider Inc. is looking for freelance science writersTBSE Class 12th (Science) board exam results declared; check scores on tripuraresults.nic.inLatest StoriesBANKING AND PAYMENTS FOR GEN Z: These digital natives are the next big opportunity - here are the winning strategiesA new Facebook privacy flaw allowed thousands of children on Messenger Kids to enter group chats with strangersThe internet is deeply confused by YouTube star Logan Paul's bizarre Fox Business interviewDoorDash is under fire for its controversial tipping policy. We asked Uber, Lyft, Instacart and other gig-economy startups about their workers' tips.Lighting struck a man and indirectly injured 7 other people over the weekend. Here's what happens to your body when it gets fried.